
### [NCIT:C45241](http://purl.obolibrary.org/obo/NCIT_C45241)
**Label:** Cutaneous B Lymphoblastic Leukemia/Lymphoma

**Subclasses:** 

**Class expressions from DL-Learner:**

- Thing 54.00%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 37.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36158](http://purl.obolibrary.org/obo/NCIT_C36158) (Chronic Clinical Course))) 37.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36157](http://purl.obolibrary.org/obo/NCIT_C36157) (Acute Clinical Course))) 37.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36156](http://purl.obolibrary.org/obo/NCIT_C36156) (Favorable Clinical Outcome))) 37.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36155](http://purl.obolibrary.org/obo/NCIT_C36155) (Accelerated Phase of Disease))) 37.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36154](http://purl.obolibrary.org/obo/NCIT_C36154) (Chronic Phase of Disease))) 37.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36141](http://purl.obolibrary.org/obo/NCIT_C36141) (Intermediate Grade Lesion))) 37.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36140](http://purl.obolibrary.org/obo/NCIT_C36140) (Grade 4 Lesion))) 37.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36134](http://purl.obolibrary.org/obo/NCIT_C36134) (Undifferentiated Lesion))) 37.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36133](http://purl.obolibrary.org/obo/NCIT_C36133) (Well Differentiated Lesion))) 37.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36132](http://purl.obolibrary.org/obo/NCIT_C36132) (Poorly Differentiated Lesion))) 37.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36131](http://purl.obolibrary.org/obo/NCIT_C36131) (Moderately Differentiated Lesion))) 37.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36130](http://purl.obolibrary.org/obo/NCIT_C36130) (Low Grade Lesion))) 37.36%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C36129](http://purl.obolibrary.org/obo/NCIT_C36129) (High Grade Lesion))) 37.36%


